Yuyu Pharma Incorporated operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yuyu Pharma Incorporated with three other
pharmaceutical manufacturers in Asia:
Ttk Healthcare Limited
sales of 5.19 billion Indian Rupees [US$77.83 million]
of which 53%
Albert David Limited
(3.22 billion Indian Rupees [US$48.33 million]
based in India
(2.96 billion Indian Rupees [US$44.45 million]
During the year ended March of 2016, sales at
Yuyu Pharma Incorporated were 69.74 billion Korean Won (US$62.28 million).
increase of 11.0%
versus 2015, when the company's sales were 62.82 billion Korean Won.
This was the fifth consecutive year of sales increases at Yuyu Pharma Incorporated
(and since 2011, sales have increased a total of 34%).